Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNR0L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,607
Award facts
- Contract value 100% obligated
- $5,607.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $5,607.07 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections. The contract, which is not set-aside and employs firm fixed-price terms, was awarded on January 6, 2026, with an ultimate completion date of January 7, 2026. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as the primary mechanism for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen's parent company, Cencora, Inc., holds a comprehensive single-award IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, providing a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The current award demonstrates AmerisourceBergen's ongoing capability to fulfill federal medical procurement requirements through open competition. Trulicity is a widely used diabetes medication that supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions requiring essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FNR0L?
SPE2DR26FNR0L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FNR0L worth?
The government has obligated $5,607 on SPE2DR26FNR0L.
Is contract SPE2DR26FNR0L an order under another contract?
Yes. SPE2DR26FNR0L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR0L competed?
The extent of competition for SPE2DR26FNR0L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award